These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35234824)

  • 1. The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    Abbasi J
    JAMA; 2022 Mar; 327(12):1113-1114. PubMed ID: 35234824
    [No Abstract]   [Full Text] [Related]  

  • 2. The COVID-19 pandemic: lifestyle and cardiovascular risk factors.
    Bhatnagar D
    Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular Outcomes in the Acute Phase of COVID-19.
    Nakano H; Shiina K; Tomiyama H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection markedly increases long-term cardiovascular risk.
    Liuzzo G; Volpe M
    Eur Heart J; 2022 May; 43(20):1899-1900. PubMed ID: 35362024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress and cardiovascular risk burden after the pandemic: current status and future prospects.
    Mattioli AV; Coppi F; Nasi M; Gallina S
    Expert Rev Cardiovasc Ther; 2022 Jul; 20(7):507-513. PubMed ID: 35727895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19.
    Parums DV
    Med Sci Monit; 2022 May; 28():e937048. PubMed ID: 35490309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID and Cardiovascular Disease: What We Know in 2021.
    Chilazi M; Duffy EY; Thakkar A; Michos ED
    Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors.
    Filipiak-Strzecka D; Plewka M; Szymczyk E; Frynas-Jończyk K; Szymczyk K; Lipiec P; Kasprzak JD
    Cardiol J; 2022; 29(5):878-879. PubMed ID: 36196658
    [No Abstract]   [Full Text] [Related]  

  • 9. Causation or confounding: why controls are critical for characterizing long COVID.
    Amin-Chowdhury Z; Ladhani SN
    Nat Med; 2021 Jul; 27(7):1129-1130. PubMed ID: 34140704
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis and management of myocardial injury in coronavirus disease 2019.
    Wei ZY; Geng YJ; Huang J; Qian HY
    Eur J Heart Fail; 2020 Nov; 22(11):1994-2006. PubMed ID: 32683753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post COVID syndrome: a new challenge for medicine.
    Tirelli U; Taibi R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4422-4425. PubMed ID: 34227079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry.
    Gómez-Mesa JE; Galindo-Coral S; Montes MC; Alarco W; Barisani JL; Magaña A; Perna ER; Romero A; Speranza M; Mendoza I; Wyss F
    Glob Heart; 2021 Feb; 16(1):14. PubMed ID: 33833938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines may cause rare, Long Covid-like symptoms.
    Couzin-Frankel J; Vogel G
    Science; 2022 Jan; 375(6579):364-366. PubMed ID: 35084966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Researchers Seek Answers for Millions With Long COVID-19.
    Mertz L
    IEEE Pulse; 2021; 12(2):17-21. PubMed ID: 33861695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
    Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
    PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of cardiovascular long COVID: where we are.
    Gandhi RS; Raman B
    Cardiovasc Res; 2024 Jul; 120(8):e30-e32. PubMed ID: 38757616
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial commentary: COVID-19 as a cardiovascular disease risk factor.
    Oktay AA; Suboc TM; Volgman AS
    Trends Cardiovasc Med; 2022 Nov; 32(8):476-478. PubMed ID: 35850405
    [No Abstract]   [Full Text] [Related]  

  • 18. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of mental health outcomes in people with covid-19: cohort study.
    Xie Y; Xu E; Al-Aly Z
    BMJ; 2022 Feb; 376():e068993. PubMed ID: 35172971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.